{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-173626","form_type":"8-K","ticker":"IMA","cik":"0001835579","company_name":"ImageneBio, Inc.","filed_at":"2025-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.227842+00:00","generated_at":"2026-05-17T20:58:43.120011+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"ImageneBio dismisses EY, appoints PwC as auditor effective Aug 2, 2025","bullets":["Audit committee dismissed Ernst & Young LLP as independent auditor effective August 2, 2025.","No disagreements or reportable events occurred during EY's audit periods (2024, 2023 and interim).","PricewaterhouseCoopers LLP appointed as new auditor for fiscal year ending Dec 31, 2025.","PwC previously served as auditor of Inmagene Biopharmaceuticals prior to merger with ImageneBio.","EY's audit reports for 2024 and 2023 were unqualified, with no adverse opinions."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-173626","json":"https://secwatch.observer/filing/0001193125-25-173626.json","markdown":"https://secwatch.observer/filing/0001193125-25-173626.md","text":"https://secwatch.observer/filing/0001193125-25-173626.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1835579/000119312525173626/0001193125-25-173626-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1835579/000119312525173626/d88091d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T20:58:43.120011+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2dc864ba5fcba2df5e6f73bae27a929cf5b5e21f","claim":"ImageneBio, Inc. engaged PricewaterhouseCoopers LLP as its auditor.","evidence_excerpt":"On August 2, 2025, upon the approval of the Audit Committee, PricewaterhouseCoopers LLP (\"PwC\") was appointed as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1835579/000119312525173626/0001193125-25-173626-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"PricewaterhouseCoopers LLP"}],"fact_type":"auditor_change"},{"claim_id":"48d7a02068b29338fffc268a52786920faec36cb","claim":"ImageneBio, Inc. dismissed Ernst & Young LLP as its auditor.","evidence_excerpt":"dismissed Ernst & Young LLP (\"EY\") as the Company’s independent registered public accounting firm, with such dismissal to become effective on August 2, 2025","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1835579/000119312525173626/0001193125-25-173626-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"dismissal"},{"label":"Auditor","value":"Ernst & Young LLP"},{"label":"Successor","value":"PricewaterhouseCoopers LLP"}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}